14-day Premium Trial Subscription Try For FreeTry Free
$4.56
-0.220 (-4.60%)
At Close: May 07, 2024
Forecast Earnings Dividends Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 ABEO stock ended at $4.56. This is 4.60% less than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 11.56% from a day low at $4.54 to a day high of $5.07.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Abeona Therapeutics Inc. prices

Date Open High Low Close Volume
Sep 20, 2013 $0.400 $0.440 $0.390 $0.410 110 000
Sep 19, 2013 $0.380 $0.420 $0.380 $0.410 90 000
Sep 18, 2013 $0.330 $0.400 $0.330 $0.400 5 000
Sep 17, 2013 $0.400 $0.400 $0.340 $0.350 25 000
Sep 16, 2013 $0.370 $0.380 $0.330 $0.330 90 000
Sep 13, 2013 $0.370 $0.370 $0.330 $0.360 115 000
Sep 12, 2013 $0.320 $0.380 $0.320 $0.380 70 000
Sep 11, 2013 $0.350 $0.370 $0.350 $0.370 15 000
Sep 10, 2013 $0.360 $0.380 $0.330 $0.380 60 000
Sep 09, 2013 $0.380 $0.410 $0.330 $0.370 25 000
Sep 06, 2013 $0.370 $0.400 $0.370 $0.400 50 000
Sep 05, 2013 $0.370 $0.390 $0.350 $0.390 25 000
Sep 04, 2013 $0.360 $0.370 $0.340 $0.370 55 000
Sep 03, 2013 $0.340 $0.360 $0.340 $0.360 30 000
Aug 30, 2013 $0.320 $0.320 $0.320 $0.320 0
Aug 29, 2013 $0.340 $0.340 $0.330 $0.340 20 000
Aug 28, 2013 $0.320 $0.340 $0.320 $0.340 10 000
Aug 27, 2013 $0.360 $0.360 $0.320 $0.340 5 000
Aug 26, 2013 $0.330 $0.350 $0.300 $0.330 130 000
Aug 23, 2013 $0.340 $0.340 $0.300 $0.330 25 000
Aug 22, 2013 $0.340 $0.340 $0.340 $0.340 5 000
Aug 21, 2013 $0.340 $0.340 $0.340 $0.340 5 000
Aug 20, 2013 $0.360 $0.360 $0.330 $0.330 5 000
Aug 19, 2013 $0.330 $0.360 $0.330 $0.360 5 000
Aug 16, 2013 $0.390 $0.390 $0.370 $0.370 30 000
Click to get the best stock tips daily for free!

About Abeona Therapeutics Inc.

Abeona Therapeutics. Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;... ABEO Profile

Golden Star

Ticker Date Change Price
BBCA May 03 1.26% $65.44
ADTH May 03 5.56% $3.24
ISTB May 03 0.0425% $47.11
WMT May 03 1.34% $59.82
UNP May 03 0.84% $240.36
INGR May 03 1.75% $114.56
ASH May 03 2.26% $95.85
WU May 03 0.449% $13.37
INVH May 03 1.72% $34.39
INTU May 03 1.89% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT